Cleveland Clinic, Case Comprehensive Cancer Center To Host National Cancer Institute Nanotechnology Symposium

Cancer Nanotechnology Symposium Brings Together Researchers to Fight Cancer

Oct 21, 2004, 01:00 ET from The Cleveland Clinic Foundation

    CLEVELAND, Oct. 21 /PRNewswire/ -- The Case Comprehensive Cancer Center,
 which includes The Cleveland Clinic Taussig Cancer Center and the Ireland
 Cancer Center at University Hospitals of Cleveland, will sponsor a National
 Cancer Institute symposium exploring the application of nanotechnology in the
 diagnosis, treatment and prevention of cancer. The symposium will be held
 Oct. 27, at the InterContinental Hotel & Conference Center Cleveland, located
 on The Cleveland Clinic campus.
     The symposium is part of a series of regional meetings the National Cancer
 Institute (NCI) is holding among cancer researchers, engineers and physical
 scientists to accelerate research in nanotechnology for breakthroughs in
 diagnosing and treating cancer patients. Nanotechnology is the creation of
 useful materials, devices and systems through the manipulation of matter on a
 miniscule scale. The NCI, part of the National Institutes of Health, recently
 launched a five-year initiative - the Alliance for Nanotechnology in Cancer -
 to support innovative research, team science and clinical application of
 nanotechnology-based cancer diagnostics and therapeutics.
     "Nanotechnology is a tremendously exciting field that affords us the
 opportunity to radically change the way we detect, treat and prevent cancer,"
 said Anna Barker, Ph.D., deputy director for Advanced Technologies and
 Strategic Partnerships at the NCI. "We could see significant and, perhaps,
 even paradigm-changing advances in the next five years. The timing of this NCI
 symposium in Cleveland is perfect to bring multiple disciplines and scientific
 collaborators together in this joint effort."
     "The symposium will highlight progress of the newest program in the Case
 Comprehensive Cancer Center where nanotechnology is being used to detect
 cancers earlier and to deliver cancer drugs with greater benefit," said
 Stanton Gerson, M.D., director of the Case Comprehensive Cancer Center and
 University Hospitals' Ireland Cancer Center. "Our investigators are developing
 new drug delivery including gene therapy through nano-scale particles and
 complexes that will improve targeted delivery to tumors. Our imaging research
 has developed new molecules that provide remarkable sensitivity and accuracy
 to cancer detection."
     "It is a great testament to the quality of science at the Lerner Research
 Institute, Taussig Cancer Center, Case Comprehensive Cancer Center and Ireland
 Cancer Center that we have attracted a meeting of this caliber to Cleveland,"
 said Derek Raghavan, M.D., Ph.D., director of The Cleveland Clinic Taussig
 Cancer Center. "There are many groups conducting research in nanotechnology in
 this area, and this meeting will allow their research agendas and experience
 to interface with scientists and clinicians who are studying cancer research.
 It will be a provocative stimulus to many new collaborations in the Ohio and
 the broader region. I commend Dr. Shuvo Roy of the Clinic for his vision of a
 NanoMedicine Summit and his leadership in bringing all of the parties
     The NCI symposium will follow The Cleveland Clinic NanoMedicine Summit
 2004, which takes place Oct. 25-26 at the InterContinental Hotel & Conference
 Center Cleveland. The event kicks off Cleveland NANO Week and is being
 presented in collaboration with Case Western Reserve University, Cornell
 University and the Maple Fund. The NanoMedicine Summit will offer insight from
 top nanotechnology experts and draw biomedical researchers and leading
 practitioners in the fields of cardiology, neurology, oncology and
     The NCI symposium is specifically targeted toward cancer researchers,
 nanoscientists, oncologists and other scientists interested in investigating
 the role of nanotechnology to address cancer research, diagnosis and
     The field of nanotechnology combines chemistry and engineering to develop
 new materials by manipulating existing materials to produce the precise
 structures needed. The materials may be smaller than a few hundred nanometers,
 or billionths of a meter. The field promises to offer revolutionary new
 opportunities in healthcare technology.
     For additional information on the NCI Cancer Nanotechnology Symposium,
 visit For more information on the
 NCI Alliance for Nanotechnology in Cancer, visit
     About Case Comprehensive Cancer Center
     The Case Comprehensive Cancer Center is a National Cancer Institute-
 designated Comprehensive Cancer Center. It integrates under a single
 leadership structure the cancer research activities of the largest biomedical
 research and health care institutions in Ohio - Case Western Reserve
 University School of Medicine, University Hospitals of Cleveland and The
 Cleveland Clinic. Case and University Hospitals are the founding institutional
 partners of the center. The Cleveland Clinic joined them in 2003 in this
 research partnership, as an educational and research affiliate of the Case
 School of Medicine. The Case Comprehensive Cancer Center brings together
 interdisciplinary research to promote discovery and rapidly bring that
 discovery to impact on patient care and cancer prevention.
     About The Cleveland Clinic Taussig Cancer Center
     The Cleveland Clinic Taussig Cancer Center comprises a team of more than
 250 expert physicians who provide a comprehensive approach to cancer treatment
 for any age group and any part of the body. The center offers a full range of
 services including cancer prevention, diagnosis, treatment and follow-up care.
 The Taussig Cancer Center participates in numerous clinical trials, providing
 patients with access to innovative treatments. The Cleveland Clinic
 Foundation, located in Cleveland, Ohio, is a not-for-profit multispecialty
 academic medical center that integrates clinical and hospital care with
 research and education. The Cleveland Clinic was founded in 1921 by four
 renowned physicians with a vision of providing outstanding patient care based
 upon the principles of cooperation, compassion and innovation. U.S. News &
 World Report consistently names The Cleveland Clinic as one of the nation's
 best hospitals in its annual "America's Best Hospitals" survey. In 2004, The
 Cleveland Clinic was ranked fourth overall. Approximately 1,200 full-time
 salaried physicians at The Cleveland Clinic and Cleveland Clinic Florida
 represent more than 100 medical specialties and subspecialties. In 2003,
 patients came for treatment from every state and from nearly 90 countries. The
 Cleveland Clinic website address is .
     About the Ireland Cancer Center at University Hospitals of Cleveland
     Staffed by a team of nearly 280 scientists and physicians, University
 Hospitals Ireland Cancer Center is among the largest cancer research and
 treatment centers in the world. It has been a National Cancer Institute-
 designated Comprehensive Cancer Center since 1998 and was previously
 designated an NCI Clinical Cancer Research Center for ten years prior to that.
 In 2003, more than 7,000 new patients received care at Ireland Cancer Center,
 and more than 800 of them enrolled in clinical trials that gave them access to
 the most promising cancer therapies. The Ireland Cancer Center has several
 community-based centers throughout University Hospitals Health System.
 Patients, families and physicians can access the Ireland Cancer Center
 Information Service by calling 800-641-2422, which handles more than 4,000
 callers annually.

SOURCE The Cleveland Clinic Foundation